Of course not, but revenue numbers will climb slowly, they are selling heart patches, not chewing gum. It will take time. If cormatrix is to become superseded, again that will take time
- Forums
- ASX - By Stock
- AVR
- Where's The Report?
Where's The Report?, page-41
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.79 |
Change
-0.120(0.67%) |
Mkt cap ! $347.9M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.79 | $30.95K | 1.724K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26 | $17.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.93 | 786 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26 | 17.720 |
1 | 586 | 17.710 |
1 | 443 | 17.700 |
2 | 276 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.930 | 786 | 4 |
17.940 | 42 | 2 |
18.000 | 312 | 2 |
18.140 | 45 | 1 |
18.240 | 500 | 1 |
Last trade - 11.28am 16/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online